| **Earnings (Loss) Per Common Share (Weighted Average Shares outstanding which are anti-dilutive) (Details) - shares shares in Thousands** | 3 Months Ended | 9 Months Ended |
|-------------------------------------------------------------------------------------------------------------------------------------------|----------------|----------------|
||
| **Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]**                                                  |           |           |   |   |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                                                           | 0              | 0              | 0 | 741 |
| Stock Appreciation Rights (SARs) [Member]                                                                                                 |           |           |   |   |
| **Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]**                                                  |           |           |   |   |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                                                           | 0              | 0              | 0 | 595 |
| Employee Stock Option [Member]                                                                                                            |           |           |   |   |
| **Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]**                                                  |           |           |   |   |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                                                           | 0              | 0              | 0 | 120 |
| Share-based compensation that may be settled in cash or shares, the effect of which is anti-dilutive                                      |           |           |   |   |
| **Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]**                                                  |           |           |   |   |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                                                           | 0              | 0              | 0 | 26 |

| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details**Name:**us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount**Namespace Prefix:**us-gaap_**Data Type:**xbrli:sharesItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details**Name:**us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                     |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockAppreciationRightsSARSMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                                                                             |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                                                                               |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |